Pulse Biosciences, Inc - Common Stock (NQ:PLSE)
All News about Pulse Biosciences, Inc - Common Stock










Pulse Biosciences Lead Therapeutic System Scores FDA Approval For Sebaceous Hyperplasia
September 26, 2022
Via Benzinga

Via Benzinga


Pulse Biosciences Reports Third Quarter 2022 Financial Results
November 10, 2022
Via Business Wire








Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022
September 21, 2022
Via Benzinga


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.